New capability replaces manual network research with instant intelligence for commercial teams
BOSTON–(BUSINESS WIRE)–#AcuityAI—AcuityMD, the AI platform for MedTech, today announced the availability of health network intelligence in AcuityAI, giving MedTech commercial teams a comprehensive view of healthcare sites, sales performance, and opportunities across health systems and purchasing networks. Sales teams can ask AcuityAI about integrated delivery networks (IDNs), group purchasing organizations (GPOs), regional purchasing coalitions (RPCs), and management services organizations (MSOs) and get instant responses grounded in AcuityMD’s trusted network data.
For MedTech commercial teams, understanding the relationships between healthcare facilities and the larger networks they belong to is critical for account planning and overall sales strategy. But evaluating opportunities across an entire health system is typically time-consuming and requires manual facility-by-facility research. Commercial teams using AcuityAI can now quickly understand how facilities are connected and assess previous sales performance across a network to identify opportunities for growth, all in a single conversation.
AcuityAI goes a step further, turning its findings into targeted site lists, reports, and analyses. MedTech commercial teams get network-based information without ever leaving the AcuityAI agent.
“MedTech commercial teams need visibility beyond what’s happening at an individual hospital or facility to understand the broader networks that influence purchasing decisions,” said Brian Collins, Chief Product Officer at AcuityMD. “For example, a national account manager preparing for a meeting with a health system can ask AcuityAI to identify every facility within that network, compare sales performance and procedure volume across locations and identify high-volume facilities where their products have limited penetration. That manager now has the network intelligence necessary to make better decisions.”
About AcuityMD
AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies – including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes’ 2025 “Next Billion-Dollar Startups” list – an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation.
Contacts
Media:
Lisa Barbadora, Barbadora INK for AcuityMD
+1 (610) 420-3413 | [email protected]
